News & Updates

Acute HF patients with diabetes derive less frailty benefit from physical rehab
Acute HF patients with diabetes derive less frailty benefit from physical rehab
15 Jan 2022

Older diabetic patients with acute heart failure who undergo physical rehabilitation have worse baseline physical function but demonstrate similar clinically meaningful improvements from the intervention, results of the Rehabilitation Therapy in Older Acute Heart Failure Patients (REHAB-HF) trial have shown. However, the benefit derived for frailty is lesser among those with diabetes.

Acute HF patients with diabetes derive less frailty benefit from physical rehab
15 Jan 2022
Fenofibrate keeps lid on triglyceride in NASH patients receiving ACC inhibitor
Fenofibrate keeps lid on triglyceride in NASH patients receiving ACC inhibitor
13 Jan 2022 byJairia Dela Cruz

For nonalcoholic steatohepatitis (NASH) patients with hypertriglyceridaemia, treatment with fenofibrate helps reduce the increases in triglyceride levels associated with acetyl-coenzyme A carboxylase (ACC) inhibition, as shown in a study.

Fenofibrate keeps lid on triglyceride in NASH patients receiving ACC inhibitor
13 Jan 2022
Diabetes mellitus may worsen COVID-19
Diabetes mellitus may worsen COVID-19
09 Jan 2022

Diabetes mellitus (DM) raises the risk of mortality and respiratory failure, as well as the need for intensive care, among patients with the coronavirus disease 2019 (COVID-19), reports a recent Philippine study.

Diabetes mellitus may worsen COVID-19
09 Jan 2022